Showing results (901-910 of 1,892) with videos related to

Sort By:
Pageof 190
Immunotherapy|June 18, 2026
Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysisWenzhe Gu, Zhengjie Shen, Jun Shi, et al.
Immunotherapy|June 19, 2026
CAR cellular therapies for acute myeloid leukemia: current landscape and future directionsJure Hederih, James Patrick, Isaac Gannon, et al.
Immunotherapy|July 9, 2026
Exploring the potential of HVJ-E for cancer immunotherapyAkikazu Harada, Keisuke Nimura
Immunotherapy|August 4, 2026
Impact of sublingual immunotherapy with dust mite drops on ECP, TARC, VCAM-1 inflammatory status in patients with allergic rhinitisBangyu Deng, Yunxia Zhao, Jisheng Liu
Immunotherapy|August 7, 2026
Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiencyRoberto Crea, Elena Perez, Chaim M Roifman
Immunotherapy|August 21, 2026
The role of artificial intelligence in predicting immunotherapy treatment outcomes based on gut microbiota composition in cancer patients: a meta-analysisLeen Alhassan, Bassel Alrabadi, Suhel F Batarseh, et al.
Immunotherapy|August 22, 2026
Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectivesAditya Raj, Zuber Khan, Mumtaz, et al.
Immunotherapy|August 24, 2026
Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancerAlfredo Tartarone, Raffaele Conca, Alessandra Perrone, et al.
Immunotherapy|October 8, 2026
Efgartigimod in the treatment of severe Guillain-Barre syndrome with overlapping autoantibody syndrome: a case report and updated clinical reviewYueqi Wang, Siqi Wang, Huijuan Fan, et al.
Immunotherapy|October 8, 2026
Liquid-liquid phase separation-related gene can predict prognosis and influence immune microenvironment in acute myeloid leukemiaXiaoyue Ren, Lijie Zhang, Linli Zhou, et al.
Pageof 190